| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6199173 | Ophthalmology | 2016 | 11 Pages |
Abstract
Premature children with severe ROP are being treated successfully with IVB monotherapy. However, recurrence is not uncommon, so vigilant follow-up is necessary to ensure timely re-treatment. Knowledge of recurrence incidence, risk factors, risk period, and characteristics allows for tailored clinical management.
Keywords
ROPNECEFPFDAaggressive posterior retinopathy of prematurityIVBIntravitreal bevacizumabNecrotizing enterocolitisROP, Retinopathy of prematurityFood and Drug Administrationgestational age95% confidence intervalVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)disc diameterBirth weight
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Helen A. MD, Megan M. MD, Alice Z. PhD,